Orchard Therapeutics plc — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2022)

$22.7M

Net Income/Loss (FY2022)

-$150.7M

Total Assets (FY2022)

$218.9M

Total Equity (FY2022)

$98.3M

Cash Flows from Operating Activities (FY2022)

-$76.0M

Source: Orchard Therapeutics plc 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.